MEI Pharma (MEIP) Postpones Special Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
MEI Pharma Postpones Special Meeting of Shareholders
July 13, 2023 4:05 PM EDTSAN DIEGO--(BUSINESS WIRE)-- MEI Pharma, Inc. (NASDAQ: MEIP) (the Company) today announced that it has postponed its special meeting in connection with the proposed transaction with Infinity Pharmaceuticals, Inc. (Infinity) to July 23, 2023, at 10:00 a.m. Eastern Time, unless postponed or adjourned to a later date.
MEI issued the following statement:
With the postponement of the special meeting, MEI shareholders have additional time to consider the merits of and vote FOR the Infinity transaction.
As a reminder, independent leading proxy advisory firms, ISS and Glass... More
